{"id":"https://openalex.org/W4385334522","doi":"https://doi.org/10.1097/adm.0000000000001202","title":"ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids","display_name":"ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids","publication_year":2023,"publication_date":"2023-07-28","ids":{"openalex":"https://openalex.org/W4385334522","doi":"https://doi.org/10.1097/adm.0000000000001202","pmid":"https://pubmed.ncbi.nlm.nih.gov/37934520"},"language":"en","primary_location":{"id":"doi:10.1097/adm.0000000000001202","doi":"https://doi.org/10.1097/adm.0000000000001202","is_oa":true,"landing_page_url":"https://doi.org/10.1097/adm.0000000000001202","pdf_url":null,"source":{"id":"https://openalex.org/S107832660","display_name":"Journal of Addiction Medicine","issn_l":"1932-0620","issn":["1932-0620","1935-3227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addiction Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/adm.0000000000001202","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050082036","display_name":"Melissa B. Weimer","orcid":"https://orcid.org/0000-0002-5624-2434","observed_orcids":["https://orcid.org/0000-0002-5624-2434"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Melissa B. Weimer","raw_affiliation_strings":["From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW); Yale School of Public Health, New Haven, CT (MBW); Division of Addiction Medicine, Highland Hospital-Alameda Health System, Oakland, CA (AAH); Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK); University of Vermont, Burlington, VT (MM); BAK and Associates, Baltimore, MD (BAK); NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW); Yale School of Public Health, New Haven, CT (MBW); Division of Addiction Medicine, Highland Hospital-Alameda Health System, Oakland, CA (AAH); Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK); University of Vermont, Burlington, VT (MM); BAK and Associates, Baltimore, MD (BAK); NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I111236770","https://openalex.org/I130769515","https://openalex.org/I2800769186","https://openalex.org/I32971472","https://openalex.org/I4210096489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112082597","display_name":"Andrew A. Herring","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800055995","display_name":"American Society of Addiction Medicine","ror":"https://ror.org/00gdzqq03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800055995"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"id":"https://openalex.org/I4210130337","display_name":"New York State Office of Alcoholism and Substance Abuse Services","ror":"https://ror.org/034y1g063","country_code":"US","type":"government","lineage":["https://openalex.org/I4210130337"]},{"id":"https://openalex.org/I4387152626","display_name":"Pinney Associates (United States)","ror":"https://ror.org/04vh4pp56","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152626"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew A. Herring","raw_affiliation_strings":["BAK and Associates, Baltimore, MD (BAK)","Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","Received for publication March 14, 2023","Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","The authors report no funding source","University of Vermont, Burlington, VT (MM)","Yale School of Public Health, New Haven, CT (MBW)","accepted June 16, 2023"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAK and Associates, Baltimore, MD (BAK)","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","institution_ids":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"raw_affiliation_string":"Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","institution_ids":["https://openalex.org/I4387152626"]},{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I4210130337"]},{"raw_affiliation_string":"Received for publication March 14, 2023","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","institution_ids":[]},{"raw_affiliation_string":"Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","institution_ids":["https://openalex.org/I2800055995"]},{"raw_affiliation_string":"The authors report no funding source","institution_ids":[]},{"raw_affiliation_string":"University of Vermont, Burlington, VT (MM)","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"Yale School of Public Health, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"accepted June 16, 2023","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008934569","display_name":"Sarah Sharfstein Kawasaki","orcid":"https://orcid.org/0000-0001-7325-7729","observed_orcids":["https://orcid.org/0000-0001-7325-7729"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800055995","display_name":"American Society of Addiction Medicine","ror":"https://ror.org/00gdzqq03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800055995"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"id":"https://openalex.org/I4210130337","display_name":"New York State Office of Alcoholism and Substance Abuse Services","ror":"https://ror.org/034y1g063","country_code":"US","type":"government","lineage":["https://openalex.org/I4210130337"]},{"id":"https://openalex.org/I4387152626","display_name":"Pinney Associates (United States)","ror":"https://ror.org/04vh4pp56","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152626"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah S. Kawasaki","raw_affiliation_strings":["BAK and Associates, Baltimore, MD (BAK)","Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","Received for publication March 14, 2023","Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","The authors report no funding source","University of Vermont, Burlington, VT (MM)","Yale School of Public Health, New Haven, CT (MBW)","accepted June 16, 2023"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAK and Associates, Baltimore, MD (BAK)","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","institution_ids":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"raw_affiliation_string":"Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","institution_ids":["https://openalex.org/I4387152626"]},{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I4210130337"]},{"raw_affiliation_string":"Received for publication March 14, 2023","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","institution_ids":[]},{"raw_affiliation_string":"Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","institution_ids":["https://openalex.org/I2800055995"]},{"raw_affiliation_string":"The authors report no funding source","institution_ids":[]},{"raw_affiliation_string":"University of Vermont, Burlington, VT (MM)","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"Yale School of Public Health, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"accepted June 16, 2023","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073052396","display_name":"Marjorie C. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800055995","display_name":"American Society of Addiction Medicine","ror":"https://ror.org/00gdzqq03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800055995"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"id":"https://openalex.org/I4210130337","display_name":"New York State Office of Alcoholism and Substance Abuse Services","ror":"https://ror.org/034y1g063","country_code":"US","type":"government","lineage":["https://openalex.org/I4210130337"]},{"id":"https://openalex.org/I4387152626","display_name":"Pinney Associates (United States)","ror":"https://ror.org/04vh4pp56","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152626"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marjorie Meyer","raw_affiliation_strings":["BAK and Associates, Baltimore, MD (BAK)","Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","Received for publication March 14, 2023","Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","The authors report no funding source","University of Vermont, Burlington, VT (MM)","Yale School of Public Health, New Haven, CT (MBW)","accepted June 16, 2023"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAK and Associates, Baltimore, MD (BAK)","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","institution_ids":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"raw_affiliation_string":"Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","institution_ids":["https://openalex.org/I4387152626"]},{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I4210130337"]},{"raw_affiliation_string":"Received for publication March 14, 2023","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","institution_ids":[]},{"raw_affiliation_string":"Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","institution_ids":["https://openalex.org/I2800055995"]},{"raw_affiliation_string":"The authors report no funding source","institution_ids":[]},{"raw_affiliation_string":"University of Vermont, Burlington, VT (MM)","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"Yale School of Public Health, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"accepted June 16, 2023","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056929445","display_name":"Bethea A. Kleykamp","orcid":"https://orcid.org/0000-0001-7117-0507","observed_orcids":["https://orcid.org/0000-0001-7117-0507"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800055995","display_name":"American Society of Addiction Medicine","ror":"https://ror.org/00gdzqq03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800055995"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"id":"https://openalex.org/I4210130337","display_name":"New York State Office of Alcoholism and Substance Abuse Services","ror":"https://ror.org/034y1g063","country_code":"US","type":"government","lineage":["https://openalex.org/I4210130337"]},{"id":"https://openalex.org/I4387152626","display_name":"Pinney Associates (United States)","ror":"https://ror.org/04vh4pp56","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152626"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bethea A. Kleykamp","raw_affiliation_strings":["BAK and Associates, Baltimore, MD (BAK)","Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","Received for publication March 14, 2023","Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","The authors report no funding source","University of Vermont, Burlington, VT (MM)","Yale School of Public Health, New Haven, CT (MBW)","accepted June 16, 2023"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAK and Associates, Baltimore, MD (BAK)","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","institution_ids":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"raw_affiliation_string":"Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","institution_ids":["https://openalex.org/I4387152626"]},{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I4210130337"]},{"raw_affiliation_string":"Received for publication March 14, 2023","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","institution_ids":[]},{"raw_affiliation_string":"Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","institution_ids":["https://openalex.org/I2800055995"]},{"raw_affiliation_string":"The authors report no funding source","institution_ids":[]},{"raw_affiliation_string":"University of Vermont, Burlington, VT (MM)","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"Yale School of Public Health, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"accepted June 16, 2023","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001258993","display_name":"Kelly S. Ramsey","orcid":"https://orcid.org/0009-0001-6287-9810","observed_orcids":["https://orcid.org/0009-0001-6287-9810","https://orcid.org/0000-0002-7013-9126"]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]},{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I2800055995","display_name":"American Society of Addiction Medicine","ror":"https://ror.org/00gdzqq03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800055995"]},{"id":"https://openalex.org/I2800769186","display_name":"Alameda Health System","ror":"https://ror.org/04hcg0q34","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210096489","display_name":"Highland Hospital","ror":"https://ror.org/00wtgx181","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"id":"https://openalex.org/I4210130337","display_name":"New York State Office of Alcoholism and Substance Abuse Services","ror":"https://ror.org/034y1g063","country_code":"US","type":"government","lineage":["https://openalex.org/I4210130337"]},{"id":"https://openalex.org/I4387152626","display_name":"Pinney Associates (United States)","ror":"https://ror.org/04vh4pp56","country_code":"US","type":"company","lineage":["https://openalex.org/I4387152626"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly S. Ramsey","raw_affiliation_strings":["BAK and Associates, Baltimore, MD (BAK)","Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","Received for publication March 14, 2023","Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","The authors report no funding source","University of Vermont, Burlington, VT (MM)","Yale School of Public Health, New Haven, CT (MBW)","accepted June 16, 2023"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BAK and Associates, Baltimore, MD (BAK)","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK)","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Division of Addiction Medicine, Highland Hospital\u2013Alameda Health System, Oakland, CA (AAH)","institution_ids":["https://openalex.org/I2800769186","https://openalex.org/I4210096489"]},{"raw_affiliation_string":"Dr Weimer reports stock options with Path CCM and consulting for CVS Health. Dr Kleykamp is an owner of BAK and Associates and a consultant for Palladian Associates, Pinney Associates, STATinMED, and Hayes, Inc/Symplr. Dr Herring, Dr Kawasaki, Dr Meyer, and Dr Ramsey report no conflicts of interest","institution_ids":["https://openalex.org/I4387152626"]},{"raw_affiliation_string":"From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR)","institution_ids":["https://openalex.org/I4210130337"]},{"raw_affiliation_string":"Received for publication March 14, 2023","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal\u2019s Web site (www.journaladdictionmedicine.com)","institution_ids":[]},{"raw_affiliation_string":"Supported by the American Society of Addiction Medicine staff Taleen Safarian, Amanda Devoto, PhD, and Maureen Boyle, PhD","institution_ids":["https://openalex.org/I2800055995"]},{"raw_affiliation_string":"The authors report no funding source","institution_ids":[]},{"raw_affiliation_string":"University of Vermont, Burlington, VT (MM)","institution_ids":["https://openalex.org/I111236770"]},{"raw_affiliation_string":"Yale School of Public Health, New Haven, CT (MBW)","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"accepted June 16, 2023","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5050082036"],"corresponding_institution_ids":["https://openalex.org/I111236770","https://openalex.org/I130769515","https://openalex.org/I2800769186","https://openalex.org/I32971472","https://openalex.org/I4210096489"],"apc_list":null,"apc_paid":null,"fwci":3.5481,"has_fulltext":false,"cited_by_count":84,"citation_normalized_percentile":{"value":0.95528517,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"17","issue":"6","first_page":"632","last_page":"639"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9629999995231628},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/opioid-withdrawal-management","display_name":"opioid withdrawal management","score":0.8059999942779541},{"id":"https://openalex.org/keywords/buprenorphine-initiation","display_name":"buprenorphine initiation","score":0.8960000276565552},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.5609999895095825},{"id":"https://openalex.org/keywords/drug-supply","display_name":"drug supply","score":0.47999998927116394},{"id":"https://openalex.org/keywords/expert-consensus","display_name":"expert consensus","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9448755979537964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9024702310562134},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.8111785650253296},{"id":"https://openalex.org/C2910878864","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonists","level":5,"score":0.5872539281845093},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5564278364181519},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5312245488166809},{"id":"https://openalex.org/C2909816603","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid-Related Disorders","level":5,"score":0.4480106830596924},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44507795572280884},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41769659519195557},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14047470688819885},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.11383140087127686},{"id":"https://openalex.org/C2777170798","wikidata":"https://www.wikidata.org/wiki/Q65087481","display_name":"Opioid epidemic","level":4,"score":0.09545725584030151},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/adm.0000000000001202","doi":"https://doi.org/10.1097/adm.0000000000001202","is_oa":true,"landing_page_url":"https://doi.org/10.1097/adm.0000000000001202","pdf_url":null,"source":{"id":"https://openalex.org/S107832660","display_name":"Journal of Addiction Medicine","issn_l":"1932-0620","issn":["1932-0620","1935-3227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addiction Medicine","raw_type":"journal-article"},{"id":"pmid:37934520","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37934520","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of addiction medicine","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.1097/adm.0000000000001202","doi":"https://doi.org/10.1097/adm.0000000000001202","is_oa":true,"landing_page_url":"https://doi.org/10.1097/adm.0000000000001202","pdf_url":null,"source":{"id":"https://openalex.org/S107832660","display_name":"Journal of Addiction Medicine","issn_l":"1932-0620","issn":["1932-0620","1935-3227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addiction Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W2073606903","https://openalex.org/W2074176517","https://openalex.org/W2149717129","https://openalex.org/W2157070455","https://openalex.org/W2413133000","https://openalex.org/W2465699960","https://openalex.org/W2654743586","https://openalex.org/W2676002102","https://openalex.org/W2796812403","https://openalex.org/W2801225511","https://openalex.org/W2891514988","https://openalex.org/W2900060230","https://openalex.org/W2903865762","https://openalex.org/W2946931292","https://openalex.org/W2990871804","https://openalex.org/W2991527114","https://openalex.org/W3020278298","https://openalex.org/W3092562216","https://openalex.org/W3094906106","https://openalex.org/W3107079922","https://openalex.org/W3119527544","https://openalex.org/W3124976223","https://openalex.org/W3127548213","https://openalex.org/W3146605924","https://openalex.org/W3178746109","https://openalex.org/W3183017455","https://openalex.org/W3200608760","https://openalex.org/W3205115907","https://openalex.org/W3213991078","https://openalex.org/W4200251774","https://openalex.org/W4205188827","https://openalex.org/W4205413787","https://openalex.org/W4206441912","https://openalex.org/W4210253499","https://openalex.org/W4220945184","https://openalex.org/W4221114005","https://openalex.org/W4226064141","https://openalex.org/W4232837283","https://openalex.org/W4283584530","https://openalex.org/W4289928095","https://openalex.org/W4292471430","https://openalex.org/W4297339150","https://openalex.org/W4318156527","https://openalex.org/W4321788998","https://openalex.org/W4323037098","https://openalex.org/W4323037551","https://openalex.org/W4361270295"],"related_works":["https://openalex.org/W4406543066","https://openalex.org/W3011423901","https://openalex.org/W4408675147","https://openalex.org/W4401503518","https://openalex.org/W2898142040","https://openalex.org/W4413375879","https://openalex.org/W3122497334","https://openalex.org/W3160783924","https://openalex.org/W4405920985","https://openalex.org/W4297339150"],"abstract_inverted_index":{"ABSTRACT:":[0],"Treatment":[1],"of":[2,19,29,46,90,92,141,148,180,196,229],"opioid":[3,142,197],"use":[4],"disorder":[5],"(OUD)":[6],"with":[7,26,94,116],"buprenorphine":[8,95,108,134,149,159,225],"has":[9,23],"evolved":[10],"considerably":[11],"in":[12,36,121,183,231],"the":[13,17,20,27,37,44,87,126,146,178,184,216,227],"last":[14],"decade":[15],"as":[16],"scale":[18],"OUD":[21,93,117,191,230],"epidemic":[22],"increased":[24],"along":[25],"emergence":[28],"high-potency":[30],"synthetic":[31],"opioids":[32],"(HPSOs)":[33],"and":[34,76,79,111,151,157,167,193,203,218,235],"stimulants":[35],"drug":[38,185],"supply.":[39],"These":[40],"changes":[41,85],"have":[42],"outpaced":[43],"development":[45],"prospective":[47,239],"research,":[48],"so":[49],"a":[50,72],"clinical":[51,63,66,88,127,209],"consideration":[52],"document":[53,68],"based":[54,70,173],"on":[55,71,174],"expert":[56,77,101],"consensus":[57,78],"is":[58,69,241],"needed":[59],"to":[60,86,119,153,212,215],"address":[61,82],"pressing":[62],"questions.":[64],"This":[65],"considerations":[67,83,128,210],"narrative":[73],"literature":[74],"review":[75],"will":[80],"specifically":[81],"for":[84,96,114,133,205,226],"practice":[89],"treatment":[91,113,123,176,199,228],"individuals":[97,115],"using":[98,224,233],"HPSO.":[99],"An":[100],"panel":[102],"developed":[103],"6":[104],"key":[105],"questions":[106],"addressing":[107],"initiation,":[109],"stabilization,":[110],"long-term":[112],"exposed":[118],"HPSO":[120],"various":[122],"settings.":[124],"Broadly,":[125],"suggest":[129],"that":[130],"individualized":[131,172],"strategies":[132],"initiation":[135,160],"may":[136],"be":[137,162,171,188,201,213],"needed.":[138,243],"The":[139],"experience":[140],"withdrawal":[143],"negatively":[144],"impacts":[145],"success":[147],"treatment,":[150,192],"attention":[152],"its":[154],"management":[155],"before":[156],"during":[158,190],"should":[161,170,187,200],"proactively":[163],"addressed.":[164],"Buprenorphine":[165],"dose":[166],"dosing":[168],"frequency":[169],"patients'":[175],"needs,":[177],"possibility":[179],"novel":[181],"components":[182],"supply":[186],"considered":[189,204],"all":[194],"forms":[195],"agonist":[198],"offered":[202],"patients.":[206],"Together,":[207],"these":[208],"attempt":[211],"responsive":[214],"challenges":[217],"opportunities":[219],"experienced":[220],"by":[221],"frontline":[222],"clinicians":[223],"patients":[232],"HPSOs":[234],"highlight":[236],"areas":[237],"where":[238],"research":[240],"urgently":[242]},"counts_by_year":[{"year":2026,"cited_by_count":23},{"year":2025,"cited_by_count":38},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-29T00:00:00"}